Cargando…
Launch sequencing of pharmaceuticals with multiple therapeutic indications: evidence from seven countries
BACKGROUND: New medicines are increasingly being identified as efficacious across multiple indications. The impact of current pricing and reimbursement policies on launch decisions across these indications remains unclear. OBJECTIVE: This paper, first, maps marketing authorisation and HTA coverage r...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923892/ https://www.ncbi.nlm.nih.gov/pubmed/36782175 http://dx.doi.org/10.1186/s12913-023-09095-2 |